Document is current
Any future updates will be listed below
-
Authors
Guermazi, Dorra
Arvanitis, Panos
Farmakiotis, Dimitrios
-
Funding
Funding for this research was provided by:
Merck
Astellas Pharma US
Eurofins Viracor BioPharma
- License Information
-
More Information
Article History
Received: 22 February 2023
Accepted: 20 March 2023
First Online: 1 April 2023
Declarations
:
: DF has received research support from Viracor, Astellas and Merck, and consultant fee from Viracor. All other authors have nothing to disclose.
: Not applicable.
: All authors agreed to the publication of the manuscript.
Free to read: This content has been made available to all.
